Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2025-12-24 @ 9:34 PM
NCT ID:
NCT00325832
Eligibility Criteria:
Inclusion Criteria:
* Both treated and untreated patients with systolic hypertension under routine FP care
* For untreated patients, routine office SBP as measured by the patient's FP at the last routine office visit using a mercury device must have SBP ≥ 160 mmHg and DBP \<= 95 mmHg
* For patients already receiving antihypertensive therapy, the last routine office BP as measured by the patient's FP using mercury sphygmomanometry must be SBP ≥ 140 mmHg and DBP \<= 90 mmHg
Exclusion Criteria:
* Presence of target organ damage such as MI, stroke, and serum creatinine twice normal
* Diabetes mellitus treated with insulin or oral hypoglycemic therapy
* Secondary hypertension
* Participation in another research study involving measurement of BP
* Patient's insistence on using self BP measurement outside of the study
* Any conditions or circumstances which might preclude the successful completion of the study
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00325832
Study Brief:
Protocol Section:
NCT00325832